Alcohol, Drugs and Addictive Behaviours
The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours.

Screening and brief intervention for alcohol problems in primary health care

 

BACKGROUND

There are many forms of excessive drinking that cause substantial risk or harm to the individual. They include high level drinking each day, repeated episodes of drinking to intoxication, drinking that is actually causing physical or mental harm, and drinking that has resulted in the person becoming dependent on alcohol. Excessive drinking causes illness and distress to the drinker and his or her family and friends. It is a major cause of breakdown in relationships, trauma, hospitalization, prolonged disability and early death. Alcohol-related problems represent an immense economic loss to many communities around the world. 

 

Screening for alcohol use: why AUDIT?

The AUDIT was developed as a simple method of screening for excessive drinking and to assist in brief assessment. It can help identify excessive drinking as the cause of the presenting illness. It provides a framework for intervention to help risky drinkers reduce or cease alcohol consumption and thereby avoid the harmful consequences of their drinking. The AUDIT also helps to identify alcohol dependence and some specific consequences of harmful drinking. Of utmost importance for screening is the fact that people who are not dependent on alcohol may stop or reduce their alcohol consumption with appropriate assistance and effort. The manual is particularly designed for health care practitioners and a range of health settings, but with suitable instructions it can be self-administered or used by non-health professionals. 

Screening for alcohol consumption among patients in primary care carries many potential benefits. It provides an opportunity to educate patients about low-risk consumption levels and the risks of excessive alcohol use. Information about the amount and frequency of alcohol consumption may inform the diagnosis of the patient's presenting condition, and it may alert clinicians to the need to advise patients whose alcohol consumption might adversely affect their use of medications and other aspects of their treatment. Screening also offers the opportunity for practitioners to take preventative measures that have proven effective in reducing alcohol-related risks. 

Development and validation of the AUDIT

The AUDIT was developed and evaluated over a period of two decades, and it has been found to provide an accurate measure of risk across gender, age and cultures. As the first screening test designed specifically for use in primary care settings, the AUDIT has the following advantages:

  • Cross-national standardization: the AUDIT was validated on primary health care patients in six countries. It is the only screening test specifically designed for international use;
  • Identifies hazardous and harmful alcohol use, as well as possible dependence;
  • Brief, rapid and flexible;
  • Designed for primary health care workers;
  • Consistent with ICD-10 definitions of alcohol dependence and harmful alcohol use;
  • Focuses on recent alcohol use.

BRIEF INTERVENTION

Brief interventions are those practices that aim to identify a real or potential alcohol problem and motivate an individual to do something about it. Brief interventions have become increasingly valuable in the management of individuals with alcohol-related problems. During the past 20 years, there have been numerous randomized trials of brief interventions in a variety of health care settings. Studies have been conducted in Australia, Bulgaria, Mexico, the United Kingdom, Norway, Sweden, the United States and many other countries. Results from these studies show that there is clear evidence that well-designed brief intervention strategies are effective, low-cost and easy to administer.

Because research has shown that brief interventions are low in cost and have proven to be effective across the spectrum of alcohol problems, health workers and policy-makers have increasingly focused on them as tools to fill the gap between the primary prevention efforts and more intensive treatment for persons with serious alcohol use disorders. It is worth noting that brief interventions are not designed to treat persons with alcohol dependence, which generally requires greater expertise and more intensive clinical management. However, they might serve well as as initial treatment for severely dependent patients seeking extended treatment.

Alongside with the companion publication on the AUDIT, WHO has also produced a manual to aid primary health care workers in administering brief interventions to persons whose alcohol consumption has become hazardous or harmful to their health. Together, these manuals describe a comprehensive approach to alcohol screening and brief intervention (SBI) that is designed to improve the health of the population and patient groups as well as individuals. 

 

Related activities:

The ASSIST project - Alcohol, Smoking and Substance Involvement Screening Test

 

 

Publications

This manual introduces the AUDIT, the Alcohol Use Disorders Identification Test, and describes how to use it to identify persons with hazardous and harmful...

From local innovation to system change – public-sector pathways for scaling community-driven initiatives on noncommunicable diseases

People and communities directly affected by noncommunicable diseases (NCDs) and mental health conditions are strategic partners in shaping effective and...

Report of the Regional Director: The work of WHO in the Western Pacific Region

The Report of the Regional Director: The work of WHO in the Western Pacific Region, 1 July 2025 − 30 June 2026, highlights progress achieved through...

Reducing alcohol-related harm: SAFER implementation handbook

Reducing alcohol-related harm: SAFER implementation handbook provides practical guidance for countries, communities and institutions seeking to implement...

Prevention and management of heat-related illness at mass gatherings: systematic reviews

Extreme heat is an increasingly important threat to health and operational continuity during mass gatherings. Climate change is increasing the frequency,...

Prevention and management of heat-related illness at mass gatherings: considerations for implementation

Extreme heat is an increasing health, safety and operational risk for mass gatherings. It can cause heat-related illness, worsen chronic disease, increase...

Prevention and management of heat-related illness at mass gatherings: developing evidence-based communication messages

Extreme heat is an important environmental and public health hazard. Exposure to high heat can cause heat-related illnesses and injuries and worsen underlying...

Prevention and management of heat-related illness at mass gatherings: risk assessment tool

Extreme heat is an increasing health, safety and operational risk for mass gatherings. It can cause heat-related illness, worsen chronic disease,...

WHO Drug Information - Volume 40, No. 3

This issue of WHO Drug Information presents Recommended International Nonproprietary Names (INN) List No. 96 for pharmaceutical substances. The names have...

WHO consolidated guidelines on tuberculosis: module 4: treatment and care, 2nd edition

WHO’s Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections maintains all current recommendations on tuberculosis (TB)...

WHO Expert Committee on Drug Dependence: forty-eighth report

The forty-eighth meeting of the WHO Expert Committee on Drug Dependence (ECDD) was convened from 20 to 22 October 2025 and was coordinated from WHO headquarters...

WHO guidelines on expanding contraceptive options

The WHO Expanding contraceptive options (ECO) guideline provides evidence-based recommendations on contraceptive methods and practices that are not currently...

Target product profiles for development of novel male contraceptive methods

Men's participation in contraception and family planning remains limited and is primarily confined to male condoms, vasectomy and withdrawal. To expand...

Filovirus collaborative open research consortium research priorities for the ongoing Bundibugyo virus disease outbreak

Bundibugyo virus remains one of the least studied Orthoebolaviruses with no licensed vaccine or treatment. This document sets out ten research priorities...

Global framework to accelerate action on avian influenza

Avian influenza is a complex global challenge with consequences for animal health, human health, biodiversity, food security and livelihoods. In recent...

Global leprosy (Hansen Disease) update, 2025: Strengtheninga person-centered approach is integral to elimination of leprosy

For this update, reporting was done for the calendar year 2025, although a few countries reported for a different 12-month period (e.g. India reported...

Implementation guidance on the management of wasting and nutritional oedema (acute malnutrition) in infants and children aged under 5 years in inpatient and outpatient settings

This implementation guidance supports governments and implementing organizations in adapting and adopting recommendations and good practice statements...

GLP1-receptor agonists landscape: manufacturer mapping and regulatory pathways

This report presents a global mapping of glucagon-like peptide-1 receptor agonist manufacturers, with a particular focus on semaglutide. The mapping describes...

WHO global research priorities and agenda for traditional, complementary and integrative medicine 2025–2034

Traditional, complementary and integrative medicine (TCIM) is used by billions of people worldwide, yet receives less than 1% of global health research...

Closing the childhood cancer survival gap through sustainable access to essential medicines: market shaping strategy (2026–2030)

Childhood cancer remains one of the starkest inequities in global health, with substantial differences in survival across countries and health systems....

Country cooperation strategy for WHO and Jordan, 2026–2030

The Country Cooperation Strategy for WHO and Jordan, 2026–2030, is WHO’s medium-term strategic framework for collaboration with the Government...

Related resources

The ASSIST-linked brief intervention for hazardous and harmful substance use

This manual is a companion to ‘The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care’. The...

The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)

The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was developed for the World Health Organization (WHO) by an international group...

Self-help strategies for cutting down or stopping substance use (ASSIST)

Substance use problems can arise as a result of acute intoxication, regular use or dependence - and from the way in which substances are used. This guide...

Guidelines for identification and management of substance use and substance use disorders in pregnancy

These guidelines contain recommendations on the identification and management of substance use and substance use disorders for health care services which...

mhGAP Intervention Guide - Version 2.0

This is the second version (2016) of the mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use (MNS) disorders in non-specialist...

mhGAP Training Manuals - for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings, version 2.0

As part of the Mental Health Gap Action Programme, WHO has developed training manuals (Training of trainers and supervisors training manual and Training...

Involvement of nurses and midwives in screening and brief interventions

Psychoactive substance use can result in a wide range of health and social problems for individuals, their families and the wider community. Globally,...